Digestive Care

Linaclotide Capsules, Strengths and Food Timing

A guide to capsule strengths, constipation indications and the instructions that belong to the exact prescribed product.

By Global Medicines ExportUpdated: Educational article

Reference table

Linaclotide reference table

This table summarises the FDA LINZESS label revised May 2026 for adults. It is an educational reference for that named US product. A prescriber selects treatment after assessing the patient, diagnosis, contraindications and tolerability.

US adult dose-reference chart

Adult condition in the US reference labelReference capsule doseFrequency
Irritable bowel syndrome with constipation290 mcgOnce daily
Chronic idiopathic constipation145 mcg or 72 mcg according to presentation or tolerabilityOnce daily

The source product and country are identified in the article. Confirm personal treatment instructions with the prescribing clinician.

What linaclotide is used for

Linaclotide acts at guanylate cyclase-C receptors in the intestine. It increases intestinal fluid secretion and can help stool passage. A clinician first distinguishes irritable bowel syndrome with constipation, chronic idiopathic constipation and other reasons for persistent constipation.

The UK Constella 290 microgram product information covers moderate to severe IBS-C in adults. The US LINZESS label includes additional indications and patient groups. These reference products explain their own authorised use. The Indian brand, destination and patient prescription require their own product-information check.

US adult dose-reference chart

This table summarises the FDA LINZESS label revised May 2026 for adults. It is an educational reference for that named US product. A prescriber selects treatment after assessing the patient, diagnosis, contraindications and tolerability.

The same label also contains pediatric information. Children need their own age- and indication-specific assessment. Capsule availability alone cannot establish which regimen is appropriate.

Food timing and capsule handling

The US label specifies an empty stomach at least 30 minutes before a meal, at approximately the same time each day. The UK Constella information also places the capsule before a meal and describes looser stools when taken with food.

Swallowing or opening instructions need the actual leaflet. LINZESS has specific directions for people who cannot swallow capsules and for certain feeding tubes. Avoid crushing or chewing its capsule contents, and have a pharmacist explain the correct method for the prescribed product.

Diarrhea and important checks

Diarrhea is the principal practical safety concern. Severe diarrhea, faintness, reduced urination or an inability to keep fluids down warrants prompt medical advice. The US label directs suspension of dosing and rehydration for severe diarrhea.

The US label contraindicates LINZESS in children younger than two and in known or suspected mechanical bowel obstruction. Tell the clinician about other bowel medicines. The UK information highlights that medicines associated with diarrhea can add to that problem. Discuss persistent or unusual abdominal symptoms before treating them as routine constipation.

Use a bowel diary to see what is changing

Count how often you have a bowel movement, but also note whether stools are still hard, how much you strain and whether you feel fully emptied. If you have IBS with constipation, track bloating and abdominal pain separately. One symptom may change before another. Bring a few representative entries to your follow-up instead of relying on your best or worst day.

Tell the clinician when you started treatment and whether any loose stools, urgency or accidents followed a change in meals or another bowel medicine. A short record helps the clinician separate tolerability from improvement. If you hear about treatment for IBS with diarrhea, the rifaximin guide explains why the predominant bowel symptom matters when discussing different medicines.

Bring persistent symptoms back to the prescriber

If you still need to strain, feel incompletely emptied, or have little improvement in pain, ask when the diagnosis and benefit of treatment should be reviewed. The UK Constella product information calls for reassessment when symptoms fail to improve. Bring a list of prescription medicines, laxatives and supplements, including any you take intermittently.

The U.S. LINZESS medication guide advises getting medical help right away for unusual or severe abdominal pain, especially with bloody or black, tarry stools. Contact your clinician promptly if you notice blood in your stools or lose weight without trying. If you miss a capsule, check your own leaflet. The U.S. LINZESS and UK Constella information both advise waiting for the next scheduled capsule.

Reading the product and preparing an enquiry

GME has separate listings for Linaclotide 72 mcg Capsules and Linaclotide 145 mcg Capsules. The 145 mcg listing identifies Colozo. Match the ingredient, capsule strength and manufacturer to the prescription and the actual pack.

For a professional sourcing enquiry, identify the destination, receiving organisation, quantity and required manufacturer leaflet. A quotation should confirm the offered presentation and available documentation. Local supply eligibility and the clinical appropriateness of treatment need separate confirmation.

Export product support

Need product, pack, and documentation details?

Global Medicines Export can support international B2B enquiries for product availability, strengths, pack information, quotation coordination, and shipment documentation review.

Common questions

Are 72 mcg and 145 mcg the same strength?

They contain different amounts per capsule. Follow the prescribed strength and ask the pharmacist to resolve any difference on the pack.

Does a higher strength work better for everyone?

The indication and individual tolerability guide selection. A clinician should assess a change in strength.

Can I take a capsule after food?

Check the actual leaflet. The referenced US and UK products place administration before a meal.

Does the US reference establish approval of Colozo abroad?

Colozo's own product information and the destination's requirements must be verified for the exact presentation.

Does going more often mean every IBS symptom is improving?

Track abdominal pain, bloating and straining as well as frequency. If one symptom improves while another remains disruptive, take both observations to your review.

Should I record laxatives I only use occasionally?

Yes. Note what you used, when you took it and how your symptoms changed. That information can help your clinician interpret loose stools or ongoing constipation.

Important medical note

This article is for general educational information only. It is not medical advice, diagnosis, or a treatment plan. Medicines should be used only under the guidance of a qualified healthcare professional. Product availability, export documentation, and quotation support do not imply that a medicine is appropriate for any individual patient.

References